AstraZeneca Drug Trial Failure Costs Billions

AstraZeneca, a British pharmaceutical company, suffered a major setback when a trial of a new heart medication proved ineffective. The failed test resulted in a loss of nearly $26 billion in market value. Despite this setback, AstraZeneca continues to grow.

Summarized from the sources above. Read the originals for the full story.